July 21, 2003 -- Selective laser trabeculoplasty (SLT) is a safe and effective primary treatment for open-angle glaucoma, according to the results of a prospective pilot study published in the July ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

Neil Minkoff, MD: As we move into different types of therapy, laser therapy is another viable treatment option. We try to understand patients on drops vs patients with implants vs patients with laser ...

Please provide your email address to receive an email when new articles are posted on . The results of a 3-year trial recently published in The Lancet provide compelling evidence that selective laser ...

Please provide your email address to receive an email when new articles are posted on . Both initial and repeat SLT were associated with IOP reduction, but repeat SLT had longer duration of effect.

More than 70 million people worldwide suffer from glaucoma. Treatment options have traditionally included eye drops to reduce the fluid the eye produces or surgery to unclog the eye's drainage. But a ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...

More than 70 million people worldwide suffer from glaucoma, a condition that causes a build-up of fluid and pressure inside the eye and can eventually lead to blindness. Treatment options have ...

One hundred and forty million people suffer from glaucoma, a degenerative eye disease that can lead to blindness. It is most prevalent among people aged 60 and up. Glaucoma is generally preventable, ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager™ DSLT, the ...